Synergy of GFlowNet and Protein Language Model Makes a Diverse Antibody Designer

Antibodies defend our health by binding to antigens with high specificity and potentiality, primarily relying on the Complementarity-Determining Region (CDR). Yet, current experimental methods of discovering new antibody CDRs are heavily time-consuming. Computational design could alleviate this burden; especially, protein language models have proven quite beneficial in many recent studies. However, most existing models solely focus on antibody potentiality and struggle to encapsulate the diverse range of plausible CDR candidates, limiting their effectiveness in real-world scenarios as binding is only one factor in the multitude of drug-forming criteria. In this paper, we introduce PG-AbD, a framework uniting Generative Flow Networks (GFlowNets) and pretrained Protein Language Models (PLMs) to successfully generate highly potent, diverse and novel antibody candidates. We innovatively construct a Products of Experts (PoE) composed by the global-distribution-modeling PLM and the local-distribution-modeling Potts Model to serve as the reward function of GFlowNet. The joint training paradigm is introduced, where PoE is trained by contrastive divergence with the negative samples generated by GFlowNet, and then guides GFlowNet to sample diverse antibody candidates. We evaluate PG-AbD on extensive antibody design benchmarks. It significantly outperforms existing methods in diversity (13.5% on RabDab, 31.1% on SabDab) while maintaining optimal potential and novelty. Generated antibodies are also found to form stable, regular 3D structures with their corresponding antigens, demonstrating the great potential of PG-AbD to accelerate real-world antibody discovery.

Authors

Institutions

Publication Details

Journal
Proceedings of the AAAI Conference on Artificial Intelligence
Published
2025-04-11
DOI
https://doi.org/10.1609/aaai.v39i21.34370
Citations
1
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
1.06

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synergy of GFlowNet and Protein Language Model Makes a Diverse Antibody Designer

Chang‐Yu Hsieh, Jian Wu, Tingjun Hou, Yiheng Zhu et al.
1 citations
Proceedings of the AAAI Conference on Artificial Intelligence
Monoclonal and Polyclonal Antibodies Research
1.06
article

Synergy of GFlowNet and Protein Language Model Makes a Diverse Antibody Designer

Chang‐Yu Hsieh, Jian Wu, Tingjun Hou, Yiheng Zhu, Mingze Yin, Mingyang Li, Yefei Wang, Jialu Wu, Wei Wu, Kun Fu, Hanjing Zhou
article en
1 citations

Abstract

Antibodies defend our health by binding to antigens with high specificity and potentiality, primarily relying on the Complementarity-Determining Region (CDR). Yet, current experimental methods of discovering new antibody CDRs are heavily time-consuming. Computational design could alleviate this burden; especially, protein language models have proven quite beneficial in many recent studies. However, most existing models solely focus on antibody potentiality and struggle to encapsulate the diverse range of plausible CDR candidates, limiting their effectiveness in real-world scenarios as binding is only one factor in the multitude of drug-forming criteria. In this paper, we introduce PG-AbD, a framework uniting Generative Flow Networks (GFlowNets) and pretrained Protein Language Models (PLMs) to successfully generate highly potent, diverse and novel antibody candidates. We innovatively construct a Products of Experts (PoE) composed by the global-distribution-modeling PLM and the local-distribution-modeling Potts Model to serve as the reward function of GFlowNet. The joint training paradigm is introduced, where PoE is trained by contrastive divergence with the negative samples generated by GFlowNet, and then guides GFlowNet to sample diverse antibody candidates. We evaluate PG-AbD on extensive antibody design benchmarks. It significantly outperforms existing methods in diversity (13.5% on RabDab, 31.1% on SabDab) while maintaining optimal potential and novelty. Generated antibodies are also found to form stable, regular 3D structures with their corresponding antigens, demonstrating the great potential of PG-AbD to accelerate real-world antibody discovery.

Proceedings of the AAAI Conference on Artificial IntelligenceVol. 39(21)
University of Science and Technology of China (CN), Shanghai Liangyou (China) (CN), Alibaba Group (China) (CN), Zhejiang University (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 36%
Monoclonal and Polyclonal Antibodies Research
1.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.